Display Settings:

Format

Send to:

Choose Destination
    J Immunol. 2008 Mar 15;180(6):3627-35.

    NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis.

    Source

    Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1578, USA. berzofsk@helix.nih.gov

    Abstract

    NKT cells are true Ag-specific T cells that also have innate properties and form a bridge between the innate and adaptive immune systems. Distinct NKT cell subsets play positive and negative regulatory roles and define a new immunoregulatory axis with broad implications for tumor immunity and other immunological and disease settings.

    PMID:
    18322166
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk